Oxurion nv to present at wet amd and dme drug development summit

Leuven, be, boston, ma, us – april 13th, 2021 – 7.30 am cet – oxurion nv (euronext brussels: oxur), a biopharmaceutical company developing next generation standard-of-care ophthalmic therapies, with a clinical stage portfolio in retinal vascular disorders, today announces that grace chang, m.d., ph.d., chief medical officer (cmo) of oxurion, will be presenting at the wet amd and dme drug development summit, taking place from april 13 to 15, 2021.
BCYC Ratings Summary
BCYC Quant Ranking